IL91482A0 - Pharmaceutical compositions containing certain heterocyclic compounds - Google Patents
Pharmaceutical compositions containing certain heterocyclic compoundsInfo
- Publication number
- IL91482A0 IL91482A0 IL91482A IL9148289A IL91482A0 IL 91482 A0 IL91482 A0 IL 91482A0 IL 91482 A IL91482 A IL 91482A IL 9148289 A IL9148289 A IL 9148289A IL 91482 A0 IL91482 A0 IL 91482A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- heterocyclic compounds
- containing certain
- certain heterocyclic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB888820651A GB8820651D0 (en) | 1988-09-01 | 1988-09-01 | Medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL91482A0 true IL91482A0 (en) | 1990-04-29 |
Family
ID=10643003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL91482A IL91482A0 (en) | 1988-09-01 | 1989-08-31 | Pharmaceutical compositions containing certain heterocyclic compounds |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0357415A3 (xx) |
| JP (1) | JPH02180824A (xx) |
| KR (1) | KR900004340A (xx) |
| AU (1) | AU627769B2 (xx) |
| CA (1) | CA1330536C (xx) |
| DK (1) | DK432689A (xx) |
| GB (1) | GB8820651D0 (xx) |
| IL (1) | IL91482A0 (xx) |
| PH (1) | PH26968A (xx) |
| ZA (1) | ZA896675B (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5276050A (en) * | 1989-08-01 | 1994-01-04 | Glaxo Group Limited | Medicaments |
| EP0492020A1 (en) * | 1990-12-21 | 1992-07-01 | Merrell Dow Pharmaceuticals Inc. | Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders |
| DK148292D0 (da) * | 1992-12-09 | 1992-12-09 | Lundbeck & Co As H | Forbindelser |
| JPH08507514A (ja) * | 1993-03-08 | 1996-08-13 | 藤沢薬品工業株式会社 | 脳血管性疾患を治療または予防するための薬物 |
| GB0305553D0 (en) * | 2003-03-11 | 2003-04-16 | Glaxo Group Ltd | Compounds |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4605652A (en) * | 1985-02-04 | 1986-08-12 | A. H. Robins Company, Inc. | Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes |
| US4624961A (en) * | 1985-04-17 | 1986-11-25 | A. H. Robins Company, Incorporated | Method for enhancing memory or correcting memory deficiency with arylamidopyrazolidines and arylamidodiazabicycloalkanes |
| GR871809B (en) * | 1986-11-28 | 1988-03-07 | Glaxo Group Ltd | Process for the preparation of tricyclic ketones |
| NZ222950A (en) * | 1986-12-17 | 1997-06-24 | Glaxo Group Ltd | Use of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl] -4h- carbazol-4-one for the manufacture of medicaments |
| EP0279990B1 (en) * | 1986-12-17 | 1995-07-12 | Glaxo Group Limited | Use of heterocyclic derivatives in the treatment of cognitive disorders |
| IE61669B1 (en) * | 1987-09-03 | 1994-11-16 | Glaxo Group Ltd | Lactam derivatives |
-
1988
- 1988-09-01 GB GB888820651A patent/GB8820651D0/en active Pending
-
1989
- 1989-08-31 DK DK432689A patent/DK432689A/da not_active Application Discontinuation
- 1989-08-31 CA CA000609996A patent/CA1330536C/en not_active Expired - Fee Related
- 1989-08-31 AU AU40967/89A patent/AU627769B2/en not_active Ceased
- 1989-08-31 JP JP1226380A patent/JPH02180824A/ja active Pending
- 1989-08-31 PH PH39187A patent/PH26968A/en unknown
- 1989-08-31 EP EP89308805A patent/EP0357415A3/en not_active Withdrawn
- 1989-08-31 KR KR1019890012466A patent/KR900004340A/ko not_active Application Discontinuation
- 1989-08-31 IL IL91482A patent/IL91482A0/xx unknown
- 1989-08-31 ZA ZA896675A patent/ZA896675B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR900004340A (ko) | 1990-04-12 |
| AU4096789A (en) | 1990-03-08 |
| EP0357415A3 (en) | 1990-08-08 |
| GB8820651D0 (en) | 1988-10-05 |
| DK432689D0 (da) | 1989-08-31 |
| PH26968A (en) | 1992-12-28 |
| JPH02180824A (ja) | 1990-07-13 |
| CA1330536C (en) | 1994-07-05 |
| DK432689A (da) | 1990-03-02 |
| EP0357415A2 (en) | 1990-03-07 |
| ZA896675B (en) | 1990-09-26 |
| AU627769B2 (en) | 1992-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL90067A0 (en) | 1alpha-hydroxyvitamin-d compounds and pharmaceutical compositions containing them | |
| GB2251791B (en) | Pharmaceutical compositions containing benzenesulphonamides | |
| GB2222772B (en) | Pharmaceutical compositions | |
| GB2219940B (en) | Pharmaceutical compositions | |
| CY1574A (en) | Pharmaceutical compositions containing 1-hydroxypyramid-2-one derivatives | |
| NZ224347A (en) | Heterocyclic compounds and pharmaceutical compositions | |
| IL92837A0 (en) | 7-oxabicycloheptyl substituted heterocyclic prostaglandin analogs and pharmaceutical compositions containing the same | |
| ZA894344B (en) | Stable pharmaceutical composition | |
| IL87435A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| IL90639A (en) | Neplanocin derivatives and analogs and pharmaceutical compositions containing them | |
| IL106385A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| GB8417170D0 (en) | Heterocyclic pharmaceutical compounds | |
| IL87494A0 (en) | Pharmaceutical compositions containing benzylpyrimidine derivatives | |
| IL106041A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| IL92314A0 (en) | Pharmaceutical compositions containing azepinones | |
| IL91482A0 (en) | Pharmaceutical compositions containing certain heterocyclic compounds | |
| IL86437A0 (en) | Pharmaceutical compositions containing certain pyranoquinoline derivatives | |
| IL91480A0 (en) | Pharmaceutical compositions containing certain heterocyclic compounds | |
| IL91481A0 (en) | Pharmaceutical compositions containing certain heterocyclic compounds | |
| IL89049A0 (en) | Pharmaceutical composition containing 4-aroylimidazol-2-ones | |
| IL87444A0 (en) | Pharmaceutical compositions containing polyaromatic compounds | |
| IL91350A0 (en) | Phenylalkylthiophenes and related compounds and pharmaceutical compositions containing them | |
| IL84857A0 (en) | Pharmaceutical compositions containing certain pyranoquinoline derivatives | |
| GB2217202B (en) | Trimelamol-containing pharmaceutical compositions | |
| NZ214764A (en) | Heterocyclic compounds and pharmaceutical compositions |